Azooka Labs Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 680.06%
(FY 2022)
- Profit -168.91%
(FY 2022)
- Ebitda -88.92%
(FY 2022)
- Net Worth -2742.80%
(FY 2022)
- Total Assets -11.68%
(FY 2022)
About Azooka Labs
The Corporate was formerly known as Bhoot Enterprises Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jahangir Benazir and Rabidass Paul serve as directors at the Company.
- CIN/LLPIN
U24233KA2016PTC086162
- Company No.
086162
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Azooka Labs Private Limited offer?
Azooka Labs Private Limited offers a wide range of products and services, including Reference Books & Study Material, Teaching Charts, Dyes & Color Additives, Natural Dyes, Medical Laboratory Instruments, Rapid Test Kit, Corona Test Kit.
Who are the key members and board of directors at Azooka Labs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jahangir Benazir  | Director | 21-Mar-2016 | Current |
| Rabidass Paul | Director | 15-Feb-2016 | Current |
Financial Performance of Azooka Labs.
Azooka Labs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 680.06% increase. The company also saw a substantial fall in profitability, with a 168.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 2742.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Azooka Labs?
In 2022, Azooka Labs had a public holding of 24.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Azooka Life Sciences LlpActive 9 years 5 monthsJahangir Benazir and Rabidass Paul are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Azooka Labs?
Unlock and access historical data on people associated with Azooka Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Azooka Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Azooka Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
